{"id":"W4417016546","doi":"10.1182/blood-2025-5523","title":"Odronextamab treatment for patients with rare subtypes of relapsed/refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (B-NHL): Updated efficacy and safety analyses from a dedicated cohort of the ELM-2 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Aggressive lymphoma; Follicular lymphoma; Lymphoma; Cohort; Dosing; Mantle cell lymphoma; Prospective cohort study; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001678808,0.0002944519,0.0007899067,0.0003687555,0.0001577309,0.0009004728,0.0003603897,0.0002156295,0.001033363],"category_scores_gemma":[0.001037812,0.0001873583,0.000993902,0.0007265471,0.0001412472,0.0004454016,0.0003706358,0.0007146935,0.0001897883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004575036,"about_ca_system_score_gemma":0.0004410263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005694417,"about_ca_topic_score_gemma":0.002437886,"domain_scores_codex":[0.999477,0.0002087947,0.0000576645,0.00008569768,0.0001119395,0.00005892977],"domain_scores_gemma":[0.9991442,0.0001786079,0.0003688432,0.00009784201,0.00008480725,0.0001256491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0979043,0.001508317,0.5466868,0.001701602,0.009321132,0.0004904636,0.0002722883,0.002908781,0.01925245,0.0003953525,0.01062445,0.3089341],"study_design_scores_gemma":[0.02013495,0.01850414,0.9219123,0.0003420882,0.00667306,0.001809192,0.0001565765,0.002180163,0.003719932,0.0005161217,0.02399596,0.00005540751],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9795659,0.01217754,0.0005600752,0.0002653048,0.00004528703,0.0002180715,0.005086068,0.00005007581,0.00203168],"genre_scores_gemma":[0.9867026,0.003023655,0.0007505495,0.0004265253,0.00008689177,0.0001985398,0.00836429,0.00001308377,0.0004339252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001678808,"threshold_uncertainty_score":0.008878529,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01020518810993391,"score_gpt":0.2701855490575468,"score_spread":0.2599803609476129,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}